ChemicalBook Chinese Germany Japanese Korean

成都美域高制药有限公司 Company Information

Company Name:    Chengdu Miracle Pharmaceutical Co., Ltd.
Tel:    19130631884 028-86136736-
Fax:    028-85265615
Email:    sales@mic-pharma.com
Nationality:    China
WebSite:    http://www.mic-pharma.com
Product List:    234
1 2 3

Product List
(2R)-1-[2-[(3-Hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)aMino]acetyl]-2-pyrrolidinecarbonitrile 1036959-27-9
(3-CarbaMoylallyl)triMethylaMMoniuM 857162-57-3
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 1354486-07-9
(4-(((benzyloxy)carbonyl)aMino)-2-fluorophenyl)boronic acid;Tedizolid interMediate I 874290-59-2
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxaMide 214398-99-9
Pidotimod Impurity A 14842-41-2
Rocuronium Bromide 119302-91-9
2-[[(5-Methoxy -1H-benziMidazol-2-yl)sulfinyl]Methyl]-3,5-diMethyl-1-4(1H)-pyridone 301669-82-9
2-Pyrrolidinecarbonitrile, 1-(chloroacetyl)-, (2R)- (9CI) 565452-98-4
3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino]propionic acid ethyl ester 211915-84-3
Pidotimod Impurity B 72744-67-3
5-broMo-2-(1H-tetrazol-5-yl)pyridine;Tedizolid interMediate E 380380-60-9
5-Methoxy-2-MercaptobenziMidazole 37052-78-1
9-METHOXY-1,3-DIMETHYL-12-THIOXO-PYRIDO[1',2',3,4]IMIDAZO[1,2-A]BENZIMIDAZOL-2-(12H)-ONE 125656-83-9
Deoxybenzoin OxiMe 26306-06-9
OMeprazole Sulfone N-Oxide 158812-85-2
Pidotimod Impurity X1 161771-75-1
Suvorexant 1030377-33-3
(R)-5-chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole 1266975-27-2
Lesinurad 878672-00-5
(R)-benzyl 5-Methyl-1,4-diazepane-1-carboxylate;Suvorexant InterMediate 1001401-60-0
2,5-Dichlorobenzooxazole 3621-81-6
(2R)-4-aMino-2-hydroxy-N,N,N-triMethyl-4-oxobutan-1-aMiniuM (carnitinaMide);Levocarnitine IMpurity C 5261-99-4
(3aR)-2-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one Hydrochloride;(R,R)-Palonosetron Hydrochloride 135729-75-8
(3aR)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one Hydrochloride;(R,S)-Palonosetron 135755-51-0
(3aS)-2-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one Hydrochloride;(S,R)-Palonosetron 135729-76-9
(3aS)-2,3,3a,4,5,6-Hexahydro-2-[(3S)-1-oxido-1-azabicyclo[2.2.2]oct-3-yl]-1H-benz[de]isoquinolin-1-one;Palonosetron N-Oxide 813425-83-1
(3-Fluorophenyl)carbaMic acid benzyl ester 149524-47-0
(3R)-3-[(1,1-diMethylethoxycarbonyl)aMino]-4-(2,5-difluorophenyl)butanoic acid;Sitagliptin iMpurity N 486459-98-7
(3R)-3-[(tert-butoxycarbonyl)aMino]-4-(2-fluorophenyl)butanoic acid;Sitagliptin iMpurity M 218608-98-1
(7-Methoxy-[1]naphthyl)-acetic acid aMide;AgoMelatine IMpurity H 138113-07-2
(R)-3-(tert-butoxycarbonylaMino)-4-(2,4-difluorophenyl)butanoic acid;Sitagliptin iMpurity L 851307-12-5
(R)-N-(4-oxo-4-(3-(trifluoroMethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)acetaMide;Sitagliptin iMpurity B 1379666-94-0
(S)-1-[2-(-3-hydroxy-adaMantan-1-ylaMino)-acetyl]-pyrrolidine-2-carboxylic acid;Vildagliptin iMpurity K 565453-39-6
(S)-3-(tert-butoxycarbonylaMino)-4-(2,4,5-trifluorophenyl)butanoic acid;Sitagliptin iMpurity P 922178-94-7
1-[3-(diMethylaMino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran-carbonitrile;EscitalopraM IMpurity A 59729-33-8
(R)-1,2,3,4-Tetrahydro-1-naphthoic acid 23357-47-3
(R)-3-(3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one 149524-42-5
1-Hydroxy-7-Methoxy-1,2,3,4-tetrahydronaphthalene;AgoMelatine IMpurity A 32820-10-3
1-oxo-1,3-dihydroisobenzofuran-5-carboxaMide;EscitalopraM IMpurity L 85118-25-8
Pidotimod Impurity D 162148-15-4
Pidotimod Impurity C 162148-17-6
3-Phenyl-4-(4-aMinosulfonylbenzyl)-5-Methylisoxazole ,Valdecoxib Sulfonyl Chloride ,valdecoxib iMpurity D;Parecoxib SodiuM IMpurity D 181696-35-5
4-(5-(hydroxyMethyl)-3-phenylisoxazol-4-yl)benzenesulfonaMide;Parecoxib SodiuM IMpurity R 181695-81-8
5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan;EscitalopraM IMpurity F 64169-45-5
7-Methoxy-α-naphthol;AgoMelatine IMpurity D 67247-13-6
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine;Tofacitinib IMpurity P 1252883-90-1
N-(4-(5-Methyl-3-phenylisoxazol-4-yl)phenylsulfonyl)propionaMide;Parecoxib SodiuM IMpurity W 198470-84-7
Pidotimod Impurity Y 161771-76-2
Rac -Sitagliptin;Sitagliptin iMpurity E 823817-56-7
RS-tofacitinib citirate;3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate;Tofacitinib IMpurity E 1092578-46-5
(4-Methylquinazolin-2-yl)Methanol;Linagliptin iMpurity N 13535-91-6
(5-broMo-2-Methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)Methanone;Canagliflozin iMpurity B 1132832-75-7
(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, N-DesMethyl Tadalafil;Tadalafil IMpurity J 171596-36-4
(6R,12aS)-6-(1,3-benzodioxol-5-yl)-2-Methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;Tadalafil IMpurity A 171596-27-3
(6S,12aR)-6-(1,3-benzodioxol-5-yl)-2-Methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;Tadalafil IMpurity C 171596-28-4
(6S,12aS)-6-(1,3-benzodioxol-5-yl)-2-Methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;Tadalafil IMpurity B 629652-72-8
(S)-3-(3-fluoro-4-(6-(2-Methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one;Tedizolid IMpurity A 1431699-67-0
2-((3aR,4S,6R,6aS)-6-aMino-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tartrate;Ticagrelor iMpurity C 376608-65-0
2-(4-fluorophenyl)-5-(5-iodo-2-Methylbenzyl)thiophene;Canagliflozin iMpurity D 898566-17-1
2,2'-[[4-[(3-Ethynylphenyl)aMino]-6,7-quinazolinediyl]bis(oxy)]bis-ethanol Monohydrochloride;Erlotinib iMpurity D 183320-12-9
2-[(RS)-[(3,5-diMethylpyridin-2-yl)Methyl]sulfinyl]-5-Methoxy-1H-benziMidazole;EsoMeprazole iMpurity B 110374-16-8
2-[[4-[(3-Ethynylphenyl)aMino]-6-(2-Methoxyethoxy)-7-quinazolinyl]oxy]acetic Acid;Erlotinib iMpurity B 882172-60-3
2-[[4-[(3-Ethynylphenyl)aMino]-7-(2-Methoxyethoxy)-6-quinazolinyl]oxy]ethanol;Erlotinib iMpurity H 183321-86-0
3-AMino-5-Methylpyrazole;Anagliptin iMpurity H 31230-17-8
3-Ethynylaniline;Erlotinib iMpurity F 54060-30-9
4-(3-Chloropropyl)Morpholine;Gefitinib iMpurity A 7357-67-7
4-Chloro-6,7-bis-(2-chloroethoxy)quinazoline;Erlotinib iMpurity C 183322-21-6
5-Methoxy-2-[[(4-Methxoy-3,5-diMethylpyridin-2-yl)Methyl]sulfonyl]-1H-benziMidazole(oMeprazole-sulfone);EsoMeprazole iMpurity D 88546-55-8
6-(2-Acetoxy-ethoxy)-4-(3-ethynyl-phenylaMino)-7-(2-Methoxy-ethoxy)quinazoline;Erlotinib iMpurity A 183320-15-2
6,7-bis(2-Methoxyethoxy)-3,4-dihydroquinazolin-4-one;Erlotinib iMpurity E 179688-29-0
6,7-DiMethoxyquinazoline-4-one;Gefitinib iMpurity E 13794-72-4
7-Methoxy-6-(3-Morpholin-4-ylpropoxy)quinazolin-4(3H)-one;Gefitinib iMpurity F 199327-61-2
Benzyl 5-Methyl-1,4-diazepane-1-carboxylate;Suvorexant InterMediate 217972-87-7
ethyl 2-Methylpyrazolo[1,5-a]pyriMidine-6-carboxylate;Anagliptin iMpurity G 1263061-14-8
Methyl 5-Hydroxy-4-Methoxyanthranilate;Gefitinib iMpurity G 50413-44-0
N-(3-chloro-4-fluorophenyl)-7-Methoxy-6-(3-Morpholinopropoxy)quinazolin-4-aMine;Apixaban iMpurityG 536759-91-8
N-[(3-Ethynyl-4-Methyl)phenyl]-6,7-bis(2-Methoxyethoxy)-4-quinazolinaMine Hydrochloride;Erlotinib iMpurity G 1346601-52-2
1-((2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)Methyl)-2-ethoxy-1h-benziMidazole-7-carboxylic acid Methyl ester 147403-52-9
1-chloroethylcyclohexyl carbonate 99464-83-2
1-Iodonaphthalene 90-14-2
(R)-(+)-3-AMinoquinuclidine dihydrochloride;Palonosetron interMediater F 123536-14-1
(3R,4R)- Cis-1-benzyl-4-methyl-3-(methylamino)piperidine dihydrochloride 1062580-52-2
(5R)-3-(3-fluoro-4-iodophenyl)-5-(hydroxyMethyl)oxazolidin-2-one 487041-08-7
Parecoxib Sodium 198470-85-8
SS-tofacitinib;3-((3s,4s)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino) piperidin-1-yl)-3-oxopropanenitrile; Tofacitinib IMpurity A 1092578-47-6
4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonamide 181695-72-7
(R)-3-(3-fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one 504438-22-6
5-methyl-3,4-diphenylisoxazole 37928-17-9
2-(2-methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 1056039-83-8
Tedizolid 856866-72-3
5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine 380380-64-3
Tedizolid phosphate 856867-55-5
Tedizolid phosphate disodiuM salt 856867-39-5
(R)-3-(4-bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one 444335-16-4
(S)-(-)-3-Aminoquinuclidine dihydrochloride 119904-90-4
(3aS)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one monohydrochloride 135729-62-3
5,6,7,8-Tetrahydro-1-naphthoic acid 4242-18-6
(S)-(-)-1,2,3,4-Tetrahydro-1-naphthoic acid 85977-52-2
5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid 956317-36-5
1 2 3

Copyright 2007©  ChemicalBook. All rights reserved.